The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

Share on Facebook Share on Twitter Under a new rule the Biden administration proposed on Tuesday, millions of Americans with ...

Shares of Eli Lilly LLY and Novo Nordisk NVO were up on Tuesday, likely due to a proposal by President Biden that Medicare ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 ...

The Biden administration wants to expand access to popular weight loss drugs like Wegovy and Ozempic. The new proposal would ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Discover the best Black Friday deals, Fort Wayne's ranking as a top retirement spot, and Walmart's pullback on diversity policies.

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

Gov. and Senator-elect Jim Justice said Tuesday he supports a plan by President Joe Biden’s administration to expand access to costly weight-loss drugs like Ozempic and Wegovy, but ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...